Aleix P.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of Tumor Infiltrating Lymphocytes in Advanced or Metastatic Triple-Negative Breast Cancer Patients
- Evaluation of Trastuzumab and Pertuzumab with FDG-PET Response-Adapted Strategy in HER2-Positive Breast Cancer: The PHERGain Study
- Phase 3 Multicenter Randomized Study of Trastuzumab Deruxtecan vs. Ado-Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer Post-Trastuzumab and Taxane Treatment
Data & Insights
Has run more than one trial at 24 of 168 partner sites.
Specializations
Breast Cancer Therapy
This investigator specializes in the treatment of HER2-positive breast cancer, with particular focus on innovative therapeutic approaches using targeted antibody treatments. Their research encompasses the evaluation of chemotherapy-free treatment protocols and response-adaptive strategies.
- Targeted Therapies
- Treatment Response Assessment
- Neoadjuvant Approaches
Primary interests include metabolic response monitoring and long-term survival outcomes in breast cancer patients.
Advanced Cancer Management
The investigator focuses on treating advanced and metastatic breast cancer, including pioneering work with tumor infiltrating lymphocytes (TILs). Their expertise extends to various breast cancer subtypes, particularly triple-negative breast cancer.
- Metastatic Disease Treatment
- Immunotherapy Approaches
- Progressive Disease Management
Special attention is given to developing treatment strategies for advanced-stage disease scenarios.
Novel Therapeutic Development
Research interests include the evaluation of targeted antibody-drug conjugates and novel therapeutic combinations. The investigator studies comparative effectiveness of new treatment modalities in hormone receptor-positive breast cancer.
- Antibody-Drug Conjugates
- Endocrine Therapy
- Treatment Sequencing
Focus areas include therapeutic innovation and treatment optimization for various breast cancer subtypes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.